by Bay Biosciences | Mar 26, 2024 | News Releases
Bay Biosciences provides high quality, clinical grade bio-specimens, matched serum, plasma and PBMC samples from patients diagnosed with systemic lupus erythematous (SLE). The K2EDTA plasma and PBMC bio-fluid specimens are processed from patient’s peripheral...
by Bay Biosciences | Feb 27, 2024 | News Releases
Bay Biosciences provides high quality, clinical grade bio-specimens, matched serum, plasma and PBMC samples from patients diagnosed with peripheral neuropathy. The K2EDTA plasma and PBMC bio-fluid specimens are processed from patient’s peripheral whole-blood using...
by Bay Biosciences | Feb 22, 2024 | News Releases
Bay Biosciences provides high quality, clinical grade bio-specimens, matched serum, plasma and PBMC samples from patients diagnosed with diabetic neuropathy. The K2EDTA plasma and PBMC bio-fluid specimens are processed from patient’s peripheral whole-blood using...
by Bay Biosciences | Jan 7, 2024 | News Releases
Bay Biosciences provides high quality, clinical grade bio-specimens, matched serum, plasma and PBMC samples from patients diagnosed with chronic urticaria. The K2EDTA plasma and PBMC bio-fluid specimens are processed from patient’s peripheral whole-blood using...
by Bay Biosciences | Jan 2, 2024 | News Releases
Bay Biosciences provides high quality, clinical grade bio-specimens, serum, plasma, PBMC and formalin fixed paraffin embedded (FFPE) tissue blocks from patients diagnosed with chronic kidney disease. The K2EDTA plasma and PBMC bio-fluid specimens are processed from...
by Bay Biosciences | Dec 7, 2023 | News Releases
Bay Biosciences provides high quality, clinical grade bio-specimens, serum, plasma, PBMC and formalin fixed paraffin embedded (FFPE) tissue blocks from patients diagnosed with renal failure. The K2EDTA plasma and PBMC bio-fluid specimens are processed from patient’s...
